All Access Articles |
- Pfizer Expects $61-64B Revenue in 2025 | 2024-12-17 | PHARMACEUTICAL
- Pfizer Stock Defies Yearly Trends, Soars Today | 2024-12-01 | PHARMACEUTICAL
- Pfizer (PFE) – What Insights Do Analysts Hold? | 2024-10-07 | PHARMACEUTICAL
- Pfizer Reports 42% Revenue Decrease in 2023 | 2024-02-22 | PHARMACEUTICAL
- Take This Into Account Before Investing in PFE | 2023-12-29 | PHARMACEUTICAL
- To the Moon? What is going on with PFE? | 2023-12-18 | PHARMACEUTICAL
- Quick Briefing on Pfizer | 2023-12-11 | PHARMACEUTICAL
- Pfizer Investors, You Need to Know This | 2023-12-02 | PHARMACEUTICAL
- Short Report on Pfizer Stock | 2023-11-28 | PHARMACEUTICAL
- Quick Look at Pfizer (PFE) | 2023-11-01 | PHARMACEUTICAL
- What Pfizer Investors Are Talking About Today. | 2023-10-25 | PHARMACEUTICAL
- Thinking of Buying Pfizer (PFE)? Here's What You Need to Know. | 2023-10-13 | PHARMACEUTICAL
- What Pfizer (PFE) Investors Need to Know | 2023-10-05 | PHARMACEUTICAL
- Getting to Know the Facts About Pfizer | 2023-10-04 | PHARMACEUTICAL
- Investing in PFE? Read Our Focused Overview. | 2023-09-20 | PHARMACEUTICAL
- What Pfizer Investors Need to Know | 2023-09-19 | PHARMACEUTICAL
- Here Are the Facts You Need to Understand PFE | 2023-08-02 | PHARMACEUTICAL
- Consider This Before Taking a Position in PFE | 2023-07-07 | PHARMACEUTICAL
- Quick Update for Pfizer (PFE) Investors | 2023-05-04 | PHARMACEUTICAL
- What Should Investors Know About Pfizer (PFE) Stock? | 2023-02-27 | PHARMACEUTICAL PREPARATIONS
- Pfizer Rises on Good News from India | 2022-11-11 | DRUG MANUFACTURERS—GENERAL